Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
No Thumbnail Available
Authors
Bianchi, G.
Czerwinski, E.
Kenwright, A.
Burdeska, A.
Recker, R. R.
Felsenberg, D.
Issue Date
2012
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Bianchi, G.; Czerwinski, E.; Kenwright, A.; Burdeska, A.; Recker, R. R.; Felsenberg, D. Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporosis International. 2012, 23(6):1769-1778.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1433-2965
0937-941X
0937-941X